However, studies have shown that it may be associated with weight loss in individuals with type 2 diabetes
Kennedy Jr, who oversees the FDA as the Health and Human Services Secretary, has expressed his support for peptides
By the end of 2025, WEGOVY was available in 52 countries worldwide, nearly doubling its global footprint, with additional launches planned for 2026, subject to regulatory approvals
This leads to decreased hunger and increased satiety
42.35% of current GLP-1 injection users also said tablets would feel more convenient, rising to 55.47% among people who had previously used GLP-1 injections
Diabetic retinopathy complications have been observed primarily with semaglutide, particularly with rapid glucose improvement in patients with pre-existing retinopathy, warranting ophthalmologic monitoring in high-risk individuals